logo

For the Inventor, By the Inventor

Chengdu, China

Hao Song

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chongqing Zein Pharmaceutical Co., Ltd, H. Lee Moffitt Cancer Center and Research Institute, Inc., Sichuan University. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hao Song. Retrieved from https://idiyas.com/inventor/hao-song-h0smmkfl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Sichuan Province, CN (2013)
  • Sichuan, CN (2017)
  • Chengdu, CN (2018 - 2019)

Company Filing History:

goldMedal3 out of 3 
 
Chongqing Zein Pharmaceutical Co., Ltd
 patents
silverMedal3 out of 312 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
bronzeMedal2 out of 263 
 
Sichuan University
 patents
4. 1 out of 14 
 
Academy of Military Medical Sciences
 patents
5. 1 out of 1 
 
Chengdu Aupone Pharmaceutical Co., Ltd
 patent
6. 1 out of 1 
 
Chongqing Zhien Pharmaceutical Co., Ltd.
 patent
where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 12583879 - Method for synthesizing C-nucleoside compound (2026-03-24),
2. 10358454 - Marinopyrrole derivatives and methods of making and using same (2019-07-23),
3. 9868747 - Marinopyrrole derivatives and methods of making and using same (2018-01-16),
4. 9700044 - Symmetrical marinopyrrole derivatives as potential antibiotic agents (2017-07-11),
5. 8431726 - Preparation method of (3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one and the product of that method (2013-04-30),

Title: Hao Song: Innovator in Marinopyrrole Derivatives

Introduction

Hao Song is a notable inventor based in Chengdu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of marinopyrrole derivatives. With a total of 5 patents, his work focuses on innovative solutions for treating resistant bacterial strains and cancer.

Latest Patents

Hao Song's latest patents include groundbreaking research on marinopyrrole derivatives and methods of making and using them. These patents describe novel cyclic and symmetric marinopyrroles with triazole substituents that exhibit antibacterial activity against resistant bacterial strains, such as MRSA. Additionally, the patents provide methods for using these compounds in the treatment or prevention of cancer and microbial infections.

Career Highlights

Throughout his career, Hao Song has worked with esteemed organizations, including the H. Lee Moffitt Cancer Center and Research Institute, Inc. and Chongqing Zein Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Hao Song has collaborated with several professionals in his field, including Yong Qin and Rongshi Li. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hao Song's contributions to the field of medicinal chemistry, particularly through his patents on marinopyrrole derivatives, highlight his role as an influential inventor. His work not only addresses critical health challenges but also paves the way for future innovations in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…